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Abstract 
Background: One of the European Union directives indicates that 10% of all fuels must be bio-synthesized by 2020. 
In this regard, biobutanol—natively produced by clostridial strains—poses as a promising alternative biofuel. One 
possible approach to overcome the difficulties of the industrial exploration of the native producers is the expression 
of more suitable pathways in robust microorganisms such as Escherichia coli. The enumeration of novel pathways is a 
powerful tool, allowing to identify non-obvious combinations of enzymes to produce a target compound.
Results: This work describes the in silico driven design of E. coli strains able to produce butanol via 2-oxoglutarate 
by a novel pathway. This butanol pathway was generated by a hypergraph algorithm and selected from an initial set 
of 105,954 different routes by successively applying different filters, such as stoichiometric feasibility, size and novelty. 
The implementation of this pathway involved seven catalytic steps and required the insertion of nine heterologous 
genes from various sources in E. coli distributed in three plasmids. Expressing butanol genes in E. coli K12 and cultiva-
tion in High-Density Medium formulation seem to favor butanol accumulation via the 2-oxoglutarate pathway. The 
maximum butanol titer obtained was 85 ± 1 mg L−1 by cultivating the cells in bioreactors.
Conclusions: In this work, we were able to successfully translate the computational analysis into in vivo applications, 
designing novel strains of E. coli able to produce n-butanol via an innovative pathway. Our results demonstrate that 
enumeration algorithms can broad the spectrum of butanol producing pathways. This validation encourages further 
research to other target compounds.
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Background
Butanol poses as a promising alternative to ethanol as a 
fuel due to its superior properties, such as higher energy 
content, less corrosiveness and higher blending capac-
ity with gasoline [1]. N-Butanol is natively produced 
together with ethanol and acetone through acetone–
butanol–ethanol (ABE) fermentation by Clostridium spe-
cies [2, 3]. Engineering its native host to improve butanol 
production is often complicated by, among other fac-
tors, the difficulty in performing genetic manipulations 
in Clostridium spp. and the formation of spores during 
butanol production in the solventogenic phase.
The expression of Clostridia butanol pathway in a more 
robust microbial host, such as Escherichia coli was firstly 
implemented by the Atsumi et al. in 2008 [4]. Neverthe-
less, the low butanol titers obtained with E. coli show 
that many challenges remain in turning this organism 
into a viable butanol production host. For example, the 
first reaction of the clostridial pathway—the condensa-
tion of two molecules of acetyl-CoA into one molecule of 
acetoacetyl-CoA—is thermodynamically unfavorable [5]. 
Also, other enzymes of this pathway appear to be poorly 
expressed in E. coli, such as butyryl-CoA dehydrogenase, 
the enzyme that catalyzes the reduction of butanoyl-CoA 
into crotonoyl-CoA [6]. Finally, the high requirement of 
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reducing power and the consequent competition with 
native fermentation pathways have also to be considered 
when optimizing butanol production in heterologous 
hosts [7]. Several rational strategies were tested in E. coli 
to increase butanol productivity, especially metabolic 
engineering approaches such as manipulation of central 
carbon metabolism, elimination of competing pathways, 
gene overexpression, cofactor balancing, expression of 
novel enzymes and consumption of different substrates 
[8].
A strategy to tackle some of the issues arisen from 
expressing clostridial enzymes is to identify alternative 
butanol biosynthetic pathways more suitable for expres-
sion in standard microbial production hosts. Until now, 
only three alternative pathways for producing butanol 
have been tested in E. coli, besides the clostridial one. 
One explores the keto-acids metabolism [9] and the other 
two explore an engineered version of the β-oxidation 
pathway present in E. coli [10, 11]. Regarding other 
microorganisms, a pathway converting malonyl-CoA into 
butanol in cyanobacteria was also reported [12].
Shen and Liao took advantage of the native amino acid 
pathway overcoming the need to involve CoA-dependent 
intermediates and producing simultaneously butanol 
and propanol [9]. In their work, E. coli was engineered to 
increase the pool of 2-ketobutyrate, a common keto-acid 
intermediate in isoleucine biosynthesis, later converted 
into butanol through the norvaline biosynthetic pathway.
Dellomonaco and coworkers engineered E. coli to acti-
vate the reverse β-oxidation cycle in the absence of the 
inducing substrate (fatty acids) [10]. The constitutive 
expression of this pathway was achieved by introducing 
mutations in the corresponding transcriptional regula-
tors (fad, ato and crp) and knocking out arcA. In a simi-
lar approach, Debabov et  al. also explored the reversed 
β-oxidation pathway, but only expressing enzymes from 
this pathway and an aerotolerant mutant adhE to convert 
butyryl-CoA into butanol [11].
In this work, we used a previously optimized hyper-
graph algorithm [13] to enumerate all possible pathways 
leading from E. coli’s metabolism to butanol. The path-
ways were analyzed to infer their feasibility to be applied 
in  vivo. First, the solutions were evaluated according to 
diverse criteria (butanol yield, number of reactions and 
novelty) to seek the most promising solutions. For each 
of the steps composing the novel pathway, enzymes were 
selected considering curated gene sequences and the 
experimental data available in the literature. Here, novel 
strains of E. coli producing butanol through a novel path-
way were developed. The resulting set of genes catalyzing 
the successive reactions from 2-oxoglutarate to butanol 
originates from diverse microorganisms.
Results
Computational analysis and manual curation 
of heterologous pathways
The set of heterologous pathways generated using our 
methodology described in [13] included 105,954 alter-
natives. After discarding all the pathways that could not 
carry flux into the target product (butanol), only 40,608 
different pathways were left. Since the clostridial butanol 
pathway possesses 6 heterologous reactions, a compet-
ing alternative should not be much larger. Therefore, 
the dataset was filtered to include only pathways with a 
maximum of 7 heterologous reactions. The application 
of this filter resulted in 316 pathways, which, in their 
turn, were ranked by size: 4 pathways with size equal to 
three reactions; 4 pathways with size equal to four reac-
tions; 120 pathways with size equal to six reactions and 
188 pathways with size equal to seven reactions. Since a 
higher number of catalytic steps do not always translate 
into a higher number of expressed proteins, we have also 
checked pathways with more than seven catalytic steps. 
The group of pathways larger than 7 steps included more 
complex variations of the shorter pathways and were dis-
carded. The precursors of these vias were E. coli metab-
olites  more distant from the central carbon and thus 
required the expression of more heterologous enzymes to 
be implemented in vivo than the shorter alternatives.
After reviewing the literature to infer their novelty, 24 
pathways, all constituted by seven catalytic steps, have 
remained and considered the most auspicious for further 
analysis and in vivo implementation. Figure 1 depicts the 
various stages of the in silico analysis from the initial set 
of pathways, as well as a representation of the final set of 
pathways using 2-oxoglutarate as the main precursor.
In this set of pathways, first 2-oxoglutarate is reduced 
to 2-hydroxyglutarate via reaction R08198 or R03534 (all 
reaction identifiers are from KEGG [14–16]). Then, in 
reaction R04000, Coenzyme A is transferred from acetyl-
CoA (releasing acetate) to 2-hydroxyglutarate forming 
2-hydroxyglutaryl-CoA, followed by its dehydration into 
glutaconyl-CoA (reaction R03937). In the next reac-
tion (R03028), glutaconyl-CoA is decarboxylated into 
crotonyl-CoA. The remaining reactions are common to 
clostridial pathway. Three different alternatives (R01171; 
R01175 and R09738) have been enumerated for the 
reduction of crotonyl-CoA in butanoyl-CoA. The last two 
steps are the successive reductions of butanoyl-CoA to 
butanal (R01173 or R01172) and of butanal to n-butanol 
(R03544 and R03545).
Although the main intermediary metabolites are com-
mon to all pathways present in the final set, the number 
of alternative routes [24] is a consequence of four out 
of the seven enzymatic steps allowing the use of differ-
ent cofactors. The main novelty of this set of 24 pathways 
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Fig. 1 Schematic representation of the successive stages of the in silico analysis. The pathways to produce butanol in E. coli were generated using 
the algorithms described in [13], were filtered and ranked, resulting in a set of the 24 most promising alternatives. The reactions constituting 
the final set of pathways are shown with indication of the respective KEGG ID. These pathways are constituted by the following enzymatic 
activities: 2-oxoglutarate reductase (R08198 and R03534); glutaconate-CoA transferase (R04000); 2-hydroxyglutaryl-CoA dehydratase (R03937); 
glutaconyl-CoA decarboxylase (R03028); butyryl-CoA dehydrogenase (R01171; R01175 and R09738); aldehyde dehydrogenase (R01172 and R01173) 
and alcohol dehydrogenase (R03544 and R03545). GSMM genome-scale metabolic model, ButOH butanol
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concerns the use of 2-oxoglutarate as the main precursor. 
2-Oxoglutarate is a keto-acid that is an intermediate in 
TCA cycle and can be formed from the oxidation of isoc-
itrate and subsequent decarboxylation of the intermedi-
ate oxalosuccinate. In anaerobic conditions, producing 
butanol from 2-oxoglutarate has a maximum theoretical 
yield similar to the clostridial and ketoacids pathways 
(clostridial and ketoacids: 0.41  g  g−1; 2OG: 0.40  g  g−1). 
The main difference between the two pathways is the 
amount of ATP that is produced in fermentative condi-
tions with butanol as main product. Producing butanol 
using the 2OG pathway requires the carboxylation of one 
phosphoenolpyruvate molecule to oxaloacetate and the 
activation of 2-hydroxyglutarate to 2-hydroxyglutaryl-
CoA using acetyl-CoA as a donor. These steps require 
extra energy input in comparison to the clostridial path-
way, which makes the 2OG pathway less advantageous 
in this regard. Although the amount of ATP generated is 
lower, the 2OG pathway compensates in terms of ther-
modynamic feasibility (see “Pathway feasibility evalua-
tion”). To the best of our knowledge, this set of pathways 
has not been reported in the literature and, for this rea-
son, was selected for further analysis.
Some of the catalytic steps constituting the pro-
posed pathway can be catalyzed using alternative cofac-
tors (NADH or NADPH/FADH2). To infer what is the 
best combination of cofactors to produce butanol in 
E. coli, all reactions were added to the E. coli genome-
scale metabolic model (GSMM) iJO1366, under anaer-
obic conditions, with glucose uptake rate equal to 
10 mmol (gDW h)−1. Butanol flux was then maximized to 
infer which reactions were active. As expected, in con-
ditions favoring an excess of NADH, all the reactions 
recycling NADH had flux through butanol production 
and the remaining ones were inactive (Additional file 1: 
Table S1).
Thus, the pathway selected for further analysis utilizes 
only NADH as the donor of reducing power and was 
named pathway 2OG.
Pathway feasibility evaluation
Since the KEGG database lacks information regard-
ing directionality, all reactions are reversible by default. 
Therefore, it was necessary to check if each reaction in 
2OG pathway occurs in the desired direction towards 
butanol; or if it is more likely to happen in the oppo-
site way. The change in Gibbs Energy (∆rG) is a practi-
cal indicator for reaction directionality: a reaction will be 
favorable in a certain direction if ∆rG is negative, mean-
ing Gibbs energy decreases during a reaction as ruled by 
the second law of thermodynamics [17]. For this reason, 
we calculated ∆rG′m, the change in Gibbs energy, con-
sidering reactants concentrations of 1  mM, a realistic 
concentration range at the cell context [18] using eQui-
librator [17]. Furthermore, to implement this pathway 
in  vivo, we searched for possible genes coding for each 
of the required enzymatic activities. For each reaction 
active during the computational simulation (Additional 
file 1: Table S1), the estimated ∆rG′m and respective gene 
sequences are shown in Table 1.
As shown in Table 1, the estimated ∆rG′m values were 
negative for all reactions with exception of the third step 
(R03937), the dehydration of 2-hydroxyglutaryl-CoA into 
glutaconyl-CoA. In this case, the estimated ∆rG′m value 
was close to 0 (0.7 ± 2.9 kJ mol−1), indicating that prob-
ably the reaction is reversible. Although a value of ∆rG′m 
close to zero suggests that neither direction is favored, 
in physiological conditions, the flux can still be forced in 
the forward direction by increasing the concentration of 
2-hydroxyglutatyl-CoA sufficiently above the concentra-
tion of the products [18]. The subsequent step (R03028) is 
much more favored in the forward direction with a ∆rG′m 
of − 35.8 ± 17.4 kJ mol−1 and K′eq 1.9 × 103. So, we expect 
that this reaction will ensure the depletion of glutaconyl-
CoA and drive the flux of the previous reaction in the 
desired direction. Regarding the other reactions of this 
pathway, the negative values of ∆rG′m suggest that the 
production of butanol from 2-oxoglutarate is thermody-
namically favorable.
After analyzing the literature, it was possible to con-
clude that all the catalytic steps constituting the proposed 
pathway have gene sequences available and experimental 
validation for the substrate. The first four reactions of the 
proposed pathway in Fig. 1 are part of the glutamate fer-
mentation via the (R)-2-hydroxyglutarate pathway. This 
pathway, firstly described in 1974 [34], is present in dif-
ferent bacteria; the best known is the strictly anaerobic 
gut bacterium Acidaminococcus fermentans [34]. More-
over, the gene sequences selected for steps 1–3 were 
already validated for glutaconate production in E. coli 
[20].
The last steps of the pathway from crotonyl-CoA to 
butanol are common to clostridial pathway. For this 
reason, different enzymes catalyzing these reactions 
have been tested in E. coli. Regarding the reduction of 
crotonyl-CoA into butyryl-CoA, the expression of the 
clostridial butyryl-CoA dehydrogenase (Bcd-EtfAB) in 
E. coli is challenging due to its oxygen sensitivity and 
the requirement of ferredoxin as the electron donor [5, 
35]. It was shown that another class of enzymes (trans-
enoyl-reductases) also catalyzes this reaction increasing 
butanol titers when replacing the complex bcd-etfAB [5]. 
Thus, the protein product of ter from Treponema denti-
cola was selected.
The two successive reductions of butyryl-CoA into 
butyraldehyde and to butanol are catalyzed by the 
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bifunctional aldehyde/alcohol dehydrogenase. For these 
two last steps, the gene adhE1 was selected since it was 
already validated for butanol production [32].
The main unknown regarding the novel butanol pro-
duction pathway depicted in Fig.  1 concerns the decar-
boxylation of glutaconyl-CoA into crotonyl-CoA. This 
step is of increased importance because it is at the inter-
section between the upstream reactions—already experi-
mentally validated for the production of glutaconate in 
E. coli [20]—and the downstream reactions, validated 
for the production of butanol [5] as shown in Table  1. 
Two genes were found to encode enzymes catalyzing 
this enzymatic step, but neither gave us enough confi-
dence to apply directly in vivo because their activity was 
not previously validated in E. coli. The decarboxylation 
of glutaconyl-CoA into crotonyl-CoA can be catalyzed 
directly by glutaconyl-CoA decarboxylase [26], or, as 
an intermediate step, by glutaryl-CoA dehydrogenase 
[25]. For this reason, two different constructions were 
designed to test these two different enzymes for this par-
ticular step.
Glutaryl-CoA dehydrogenase is a bifunctional enzyme 
that catalyzes the decarboxylation of glutaconyl-CoA into 
crotonyl-CoA, using glutaryl-CoA as the initial substrate 
and glutaconyl-CoA as an intermediate [36]. Enzymatic 
assays showed that this enzyme was able to catalyze 
directly the conversion of glutaconyl-CoA into crotonyl-
CoA with an activity 1.2–1.6 times higher than for the 
first step [25]. This enzyme was identified in cell-free 
extracts of Pseudomonas sp when grown anaerobically 
Table 1 Estimated change in Gibbs energy and experimental validation for the reactions constituting the 2-oxoglutarate 
pathway
The estimated change in Gibbs free energy (ΔrG′
m) values were computed with eQuilibrator [17] for each reaction constituting the novel pathway to produce butanol 
from 2-oxoglutarate (assumptions: reactant/product concentrations of 1 mM), as well as equilibrium constant (K′eq) values at a pH of 7 and an ionic strength of 0.1 M. 
The encoding gene and respective microorganism, as well as references of enzymatic activity validation with the substrate and experimental validation in Escherichia 
coli are also shown, plus the EC number and NCBI accession number
Exp experimental, EC enzyme commission, AF Acidaminococcus fermentans, CS Clostridium symbiosum, PA Pseudomonas aeruginosa, TD Treponema denticola, CA 
Clostridium acetobutylicum
a This refers to the substrate in italics in the reaction column
b Only the enzymes converting the (R)-isomer were considered. There are two enantiomers of 2-hydroxyglutarate; however, in KEGG (the database from which the 
reactions were retrieved), these variations are not represented. Depending on the enzyme, one of these forms can be preferably synthesized. The two subsequent 
reactions are part of the glutamate degradation pathway, existent is some microorganisms, where the (R)-isomers of the other compounds are preferably consumed
Step Reaction ΔrG′
m 
(KJ mol−1)
K′eq E.C. number Enzyme Gene NCBI 
accession no
Enzymatic 
 activitya
Exp. 
validation 
in E. coli
1 2-Oxoglutarate + NADH + H+⟺ 2-Hydrox-
yglutarateb + NAD+
− 22.6 ± 3.6 9.2 × 103 EC 1.1.1.399 2-Oxoglutarate 
reductase
hgdH [AF]
WP_012938338
[19] [20, 21]
2 Acetyl-CoA + 2-Hydroxyglutarate ⟺ Ace-
tate + 2-Hydroxyglutaryl-CoA
− 8.6 ± 15.3 32.1 EC 2.8.3.12 Glutaconate 
CoA-
transferase 
(subunits α 
and β)
gctA [AF]
WP_012939156.1
[22]
gctB [AF]
WP_012939155.1
3 2-Hydroxyglutaryl-CoA ⟺ Glutaconyl-
CoA + H2O
0.7 ± 2.9 0.751 EC 4.2.1.167 (R)-2-Hydroxy-
glutaryl-CoA 
dehydratase
Subunits α, β 
and activator
hgdA [CS]
WP_003501726.1
[23]
hgdB [CS]
WP_003501727.1
hgdC [AF]
WP_012939153.1
[24]
4 Glutaconyl-CoA ⟺ Crotonyl-CoA + CO2 − 35.8 ± 17.4 1.9 × 103 EC 1.3.8.6 Glutaryl-CoA 
dehydroge-
nase
gcdH [PA]
WP_042912665.1
[25] –
EC 4.1.1.70 Glutaconyl-
CoA decar-
boxylase α 
subunit
gcdA [CS]
WP_003501720.1
[26] –
5 Crotonyl-CoA + NADH + H+ ⟺ Butanoyl-
CoA + NAD+
− 40.0 ± 17.0 1.0 × 107 EC 1.3.1.44 Trans-2-
enoyl-CoA 
reductase
ter [TD]
WP_002681770.1
[27] [5, 28–30]
6 Butanoyl-CoA + NADH + H+⟺ Buta-
nal + CoA + NAD+
− 57.0 ± 16 9.6 × 109 EC 1.2.1.57 Aldehyde/
alcohol 
dehydroge-
nase
adhE1 [CA]
WP_077851567.1
[31] [32, 33]
7 Butanal + NADH + H+ ⟺ Butanol + NAD+ − 24.2 ± 4.8 1.8 × 104 EC 1.1.1.1
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in aromatic compounds [25]. A curated gene sequence 
encoding this enzyme was available for Pseudomonas 
aeruginosa PAO1.
Glutaconyl-CoA decarboxylase is a four-subunit mem-
brane-bound enzyme that catalyzes the conversion of 
glutaconyl-CoA into crotonyl-CoA, working as a biotin-
dependent sodium pump [37]. This enzyme is involved 
in the fermentation of glutamate by strictly anaerobic 
bacteria. Glutaconyl-CoA decarboxylases from the bac-
teria Acidaminococcus fermentans [38] and Clostridium 
symbiosum [26] were crystalized and characterized. 
Considering that the butanol production pathway tested 
here requires a high number of heterologous genes, we 
decided to express only the α-subunit of the glutaconyl-
CoA decarboxylase (encoded by gcdA), which is able to 
catalyze the reaction as long as biotin is also supplied. 
Regarding the microorganism source, within the best 
studied glutaconyl-CoA decarboxylases, we have selected 
Clostridium symbiosum because the Km for biotin was 
14-times lower than the value obtained for the α-subunit 
of glutaconyl-CoA decarboxylase from A. fermentans 
[26].
In vivo implementation
Two different constructions were designed with all 
the genes constituting the pathway and two different 
enzymes for the fourth step: one expressing a glutaryl-
CoA dehydrogenase (gcdH) from Pseudomonas aer-
uginosa and another one expressing the α-subunit of 
glutaconyl-CoA decarboxylase (gcdA) from C. symbio-
sum. These genes were introduced in BL21 (De3) (OG1 
and OG3)- and K-12-based cells (OG2 and OG4) as 
depicted in Fig. 2. The developed strains were cultivated 
in the complex medium TB and in the synthetic HDM 
medium, induced with 0.5 of IPTG and immediately 
Fig. 2 Butanol titer (mg L−1) for the different strain designs in TB medium and HDM medium. The different enzymes expressed in each strain are 
indicated. In all experiments, strains were grown in shake flasks until reaching 0.4–0.5  OD600. 0.5 mM of IPTG was then added to the medium and 
cells transferred to sealed serum bottles. Data are shown as mean ± SD from three independent experiments. ND not detected; the detection limit 
of the method is 3 mg L−1. 2OG 2-oxoglutarate, 2-HdxG 2-hydroxyglutarate, HdxG-CoA 2-hydroxyglutaryl-CoA, Gtc-CoA glutaconyl-CoA, Crt-CoA 
crotonyl-CoA, But-CoA butanoyl-CoA, ButOH butanol, acCoA ACETYL-CoA, AcAcCoA acetoacetyl-CoA, 3-HB-CoA 3-hydroxybutyryl-CoA, Cit citrate, 
Lact lactate, OAA oxaloacetate, PEP phosphoenolpyruvate
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switched to sealed serum bottles. The results are summa-
rized in Fig. 2.
The butanol titers obtained by testing the fours strains 
expressing the 2OG pathway showed that this compound 
could only be detected in strains where glutaryl-CoA 
dehydrogenase (OG1 and OG2) was expressed (detec-
tion limit is 3 mg L−1). Data retrieved from the literature 
showed that the sole expression of the α-subunit of gluta-
conyl-CoA decarboxylase has a Vmax 1000 times lower 
than the full enzyme [26]. Therefore, it is not possible 
to affirm that this enzyme is not a viable option for the 
proposed pathway. Moreover, there is a discrepancy in 
the copy number of the plasmid used for expressing the 
two enzymes: pCOLADuet possesses 20–40 copy num-
ber per cell (plasmid used for gcdA), while pRSFDuet (the 
plasmid used to express gcdH) has a copy number higher 
than 100 plasmids per cells. To confirm that gcdH is more 
suitable for this pathway, both genes should be cloned 
using the same conditions. Given the lack of butanol pro-
duction in the strains expressing gcdA and the challenge 
of expressing all four subunits of the transmembrane 
glutaconyl-CoA decarboxylase, further experiments with 
this pathway were performed only for the strains using 
the glutaryl-CoA dehydrogenase.
As depicted in Fig.  2, we implemented a few varia-
tions of the clostridial pathway in E. coli and compared 
with the 2OG pathway in terms of butanol production 
using the same culture conditions. For the first step of 
this route—the thermodynamically unfavorable con-
densation of two molecules of acetyl-CoA into one of 
acetoacetyl-CoA—two enzymes were tested: the protein 
products of the clostridial thl and of the E. coli native 
atoB. Both derivative pathways were expressed in BL21 
(ACT1 and ACT3) and in K12 cells (ACT2 and ACT4). 
Butanol accumulation was detected in both designs 
either expressing thl or atoB. In accordance to the data 
previously reported, the cells expressing atoB (ACT3 
and ACT4) achieved higher butanol titers than the ones 
expressing thl (ACT1 and ACT2) [9].
The maximum butanol titer obtained in serum bottles 
(75 ± 4 mg L−1) was achieved by cultivating OG2 (E. coli 
K12 host) in HDM medium. This value is 1.8-fold greater 
than the maximum butanol production obtained for the 
ACT strains (41 ± 8 mg L−1), presenting a good indicator 
of the potential of this novel pathway.
For both OG1 and OG2 strains, HDM formulation 
seems to favor butanol production over TB medium. 
Contrarily, strains expressing clostridial pathway (ACT) 
achieved higher butanol titers in TB medium. Other 
publications have demonstrated that the presence in the 
medium of complex nutrients is beneficial for butanol 
production through the clostridial pathway and its deriv-
atives. By removing complex nutrients such as tryptone 
and yeast extract from the medium, the authors observed 
a reduction in butanol production [5, 30]. The contrasting 
behavior between the two butanol production pathways 
is likely to be a consequence of the different precursors 
used by each pathway and the influence of the complex 
nutrients on their availability.
To determine if the medium formulation used here 
could be further optimized, we omitted some of the extra 
components added in the synthetic medium formulation 
(HDM) (Additional file 2: Fig. S1). The formulation that 
provided the highest butanol titer for OG2 was the one 
including all the supplements. Surprisingly, for OG1, the 
omission of iron (III) citrate and riboflavin had a posi-
tive impact in the final butanol titer, representing a 1.5-
fold improvement when compared with the complete 
formulation of HDM. Iron(III) citrate and riboflavin 
were supplemented due to the reported requirements of 
2-hydroxyglutarate dehydratase (encoded by the genes 
hgdABC) [20]. Given the direct connection between 
butanol production in the strains tested and 2OG, we 
expected that the omission of glutamate would cause 
the greatest impact on butanol titer. However, the results 
actually showed that omitting the mixture of amino acids 
resulted in a lower butanol accumulation than the single 
omission of glutamate.
Regarding the host strain used for butanol produc-
tion, we observed that BL21 strains provided the highest 
butanol titers when expressing clostridial pathway and 
K12 based strains showed increased butanol production 
through the 2OG pathway.
To validate that the pathway introduced into E. coli 
was using 2-oxoglutarate as starting precursor, strains 
expressing only a part of the pathway, CT_OG1 and 
CT_OG2, were cultured in the same fashion as described 
before for experiments using TB and HDM media. These 
strains only expressed the final five catalytic steps of the 
pathway. The main goal was to infer if some alterna-
tive precursors were being used directly from the media 
by the enzymes catalyzing the final five reactions of the 
proposed pathway. Since butanol was not detected in 
all the performed experiments, we can conclude that all 
the three plasmids are needed to produce a detectable 
amount of butanol.
Butanol production in bioreactors
Under anaerobic conditions, E. coli produces mixed-acid 
fermentation products decreasing the pH of the medium, 
which can slow, or even stop growth. For this reason, 
OG2 (the strain that provided the greatest titers in the 
serum bottle experiments—Fig.  2) was cultivated under 
controlled conditions in a bioreactor.
OG2 was cultivated with 0.5-l working volume in a 
2-l bioreactor using HDM medium. Samples were taken 
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to measure cell density and concentration of excreted 
metabolites with HPLC and GC-FID analysis. Figure  3 
summarizes the obtained results.
It is possible to observe in Fig.  3 that the maximum 
butanol titer (85 ± 1  mg  L−1), obtained after 50  h, rep-
resented a 1.1-fold improvement, comparing with the 
results obtained in serum bottles for OG2 strains (Fig. 2). 
We can see a biomass-product coupled behavior by ana-
lyzing the growth curve and the butanol production 
profile in Fig.  3a. During the first 3  h, there is growth 
under aerobic conditions and at this moment, 0.5  mM 
of IPTG was added to the medium. Between 5 and 12 h, 
the growth rate and glucose consumption decreased. The 
switch to anaerobic conditions and the metabolic burden 
imposed by IPTG induction can explain this decelera-
tion. Next, between 12 and 50 h, cells continuously grew, 
consuming glucose, producing butanol and mixed-acid 
fermentation products until reaching a stationary phase.
Butanol was first detected at 24 h of fermentation and 
its accumulation increased until 50  h. For this moment 
on, butanol concentration remained constant, coincid-
ing with the glucose exhaustion and biomass growth pla-
teau. In the experiments using serum bottles (Fig. 2), the 
greatest titer was only achieved after 96 h of cell growth. 
So, we can conclude that cultivating the cells under 
controlled conditions has accelerated butanol produc-
tion, although the increment on titers has been modest. 
Nevertheless, even in bioreactors, the growth rate (µ) 
was low (0.035 ± 0.002  h−1), representing a duplication 
time of 19.9 ± 1.3  h. Analyzing Fig.  3b, lactate was the 
major fermentation product released by the cells. In fact, 
the yield of lactate on glucose was 0.48 ± 0.02  gLac  g−1gluc. 
Butanol yield on substrate was the lowest one within 
the detected products, namely succinate, ethanol, lac-
tate and acetate. So, during the anaerobic growth, E. coli 
preferably uses the native pathways to recycle the excess 
of NADH instead of the butanol pathway, even with the 
high amount of heterologous proteins being presum-
ably expressed. This was also observed by other groups 
expressing the clostridial pathway in E. coli, in which 
Fig. 3 Physiological characterization of the strain OG2 in bioreactor. a Growth-curve (optical density at 600 nm) profile and butanol concentration; 
b glucose and end-products concentrations during the fermentation and c specific growth rate (µ), duplication time (td) and butanol, ethanol, 
succinate, acetate and lactate yields (Y) on glucose. Cells were cultivated aerobically in HDM medium and induced with 0.5 mM of IPTG at 0.4–0.5 
 OD600. At this moment, anaerobic conditions were created by turning off the air flow and waiting for the leftover oxygen to be consumed. Data are 
shown as mean ± SD of three independent experiments. ButOH butanol, EtOH ethanol, Succ succinate, Acet acetate, Lact lactate
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butanol accumulation increased after deleting mixed-
acid fermentation pathways [5, 28].
Discussion
The main objective of this study was to rationally design 
a new microbial cell factory able to produce butanol 
through a novel pathway, generated by a hypergraph 
algorithm. Furthermore, the analysis carried using sev-
eral in silico tools aimed to save time in the lab by avoid-
ing a trial and error experimental approach.
From the initial set of 105,954 different pathways, only 
40,608 routes could actually produce butanol when inte-
grated into an E. coli model. Since stoichiometry is not 
considered by the enumeration algorithm, the FBA simu-
lations allowed to identify the stoichiometrically feasible 
pathways, i.e., with butanol flux. The successive filters 
applied (based on size and novelty) allowed the identifi-
cation of a set of 24 pathways. These pathways catalyze, 
with some alternative reactions, the conversion of 2-oxo-
glutarate into n-butanol. Within E. coli and maximizing 
butanol production in silico under anaerobic conditions, 
NADH would be the most efficient cofactor to produce 
butanol using this pathway. By retrieving the literature 
and analyzing databases, we selected the most suit-
able enzymes for the different steps of this pathway. The 
in vivo implementation of this pathway allowed butanol 
production when the fourth step was catalyzed by glu-
taryl-CoA dehydrogenase (OG1 and OG2) expressed in 
pRSFDuet, but not when the α-subunit of the glutaconyl-
CoA decarboxylase was used in its place (OG3 and OG4) 
using an expression vector with a lower copy number—
pCOLADuet. To the best of our knowledge, this was the 
first time that butanol was produced in E. coli through 
this pathway using 2OG as precursor.
Escherichia coli K12 MG1655 was used as host for 
expressing the 2OG pathway, considering that all the in 
silico simulations were based on iJO1366 [39], a genome-
scale metabolic model developed for this strain. We also 
tested E. coli BL21 (DE3) to produce butanol for being 
considered more suitable for heterologous gene expres-
sion. In fact, E. coli genome had been modified in BL21 
(DE3) to improve protein expression, lacking genes 
encoding proteases (such as Lon and OmpT) and pre-
venting plasmid loss by the mutation in gene hsdB [40]. 
Nevertheless, the results (Figs.  2, 3) showed that E. coli 
K12 produced higher titers of butanol through the 2OG 
pathway than the BL21 equivalent. Since recombinant 
protein production is expected to be favored in BL21 
hosts, a possible explanation for the results may be the 
metabolism of the two different strains. Reportedly, in 
BL21 cells, the enzymes responsible for the glyoxylate 
bypass are constitutively expressed; while in K12 cells, 
their expression is extremely regulated [41]. This pathway 
converts directly isocitrate and acetyl-CoA into malate 
and succinate, avoiding the two successive decarboxy-
lations of isocitrate into 2OG and succinyl-CoA [41]. 
Assuming that the glyoxylate bypass is only active in 
OG1 strains when glucose is the main carbon source, the 
respective flux through the oxidative branch of the TCA 
cycle will be lower than in OG2. Consequently, the accu-
mulation of 2OG will be reduced [42]. So, we hypothesize 
that, in OG2 strains, the 2OG pool is higher, increasing 
the flux towards the heterologous production of butanol. 
Moreover, the superior butanol production results when 
expressing the clostridial pathway in BL21-based strains 
(Fig.  2) support this hypothesis, since acetyl-CoA is the 
main precursor of the clostridial pathway. As future 
work, the expression of 2OG pathway into E. coli K12 
JM109 hosts could provide higher butanol titers, since 
the genome of these K12-based strains was modified to 
enhance recombinant protein expression, similarly to 
BL21 cells [43].
It is important to point out that the major differ-
ence between the two pathways is the precursor. Both 
metabolites (acetyl-CoA and 2-oxoglutarate) are part 
of the central carbon metabolism and intermediates 
in fundamental biochemical pathways. The immediate 
advantage of the 2OG pathway is the thermodynami-
cally favorable first step (ΔrG′m = − 22.6 ± 3.6 kJ mol−1) 
to avoid the unfavorable condensation of two molecules 
of acetyl-CoA (ΔrG′m = 26.1 ± 1.7  kJ  mol−1). However, 
under anaerobic conditions, the TCA cycle is down-
regulated and 2OG is only synthesized to support bio-
mass formation. The impact of draining 2-oxoglutarate 
from the TCA cycle has not been studied before. In the 
literature, there are examples of successfully expressed 
heterologous pathways in E. coli using 2OG as sub-
strate for the production of glutaconate [20] and glu-
tarate [21] under anaerobic conditions. In these works, 
the titers achieved are not large; so, it is not possible to 
infer the effect of the 2OG depletion. The simulations 
we performed with the novel butanol pathway showed 
that even when all pathways for mixed-acid fermen-
tation are deleted (lactate, ethanol, acetate) the 2OG 
pathway is enough to support anaerobic growth with a 
reduction of the maximum growth rate to 50% of the 
wild type.
OG strains accumulated more butanol in the defined 
medium than in the complex counterpart (Fig.  2). 
Hence, the production of butanol seems to be positively 
affected by the defined HDM formulation. We hypoth-
esize that the supplementation in HDM medium of 
amino acids in the free form—tryptone could contain 
small peptides in TB medium—positively impacts the 
2OG pool increasing butanol accumulation. This is also 
supported by the data shown in Additional file  2: Fig. 
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S1, where the omission of amino acids solution from 
HDM medium caused the highest reduction on butanol 
titers. The opposite results obtained with ACT strains, 
where TB medium provided the maximum butanol 
titers, agree with what is reported in the literature, 
where the omission of complex nutrients had a nega-
tive impact on butanol accumulation when expressing 
the clostridial pathway [4, 5, 30, 44]. The hypotheses 
for this behavior include the high demand of this path-
way for acetyl-CoA and NADH, limiting the available 
resources for protein synthesis [30] and the role of yeast 
extract as a nitrogen donor, increasing biomass growth 
and butanol titers [5].
The obtained titers are far below the industrial require-
ments, and thus further optimization to achieve indus-
trial requirements is needed. Additional metabolic 
engineering strategies can help to develop more efficient 
cell factories. An obvious next step is the already men-
tioned deletion of the pathways for the competing fer-
mentation products. Further exploration of strategies to 
improve the accumulation of the precursor 2-oxoglutar-
ate could help to improve butanol titers obtained through 
the respective pathway, while the detection of pathway 
intermediates could allow to identify the bottleneck(s), 
providing insight for the next steps for strain engineering 
[28].
Other strategies include the use of RBS strength pre-
diction algorithms or manipulation of mRNA stability 
[45] to fine-tune gene expression [46]. Also, application 
of techniques such as transcriptomics, fluxomics and 
metabolomics could give insight on the metabolism of 
the different strains, allowing to identify possible meta-
bolic engineering strategies to increase butanol accumu-
lation [47].
Conclusions
In this work, we were able to design novel strains of E. 
coli capable of producing butanol through a novel path-
way generated by a hypergraph algorithm using 2-oxog-
lutarate as the precursor.
Escherichia coli OG2, using E. coli K12 MG1655 DE3 
as host, provided higher final titers of butanol than using 
BL21. The greatest titer (75 ± 4 mg L−1) was obtained by 
cultivating OG2 strains in HDM medium and inducing 
with 0.5 mM of IPTG.
The maximum titers obtained for this novel pathway 
are still far below from those required for industrial pur-
poses. The results obtained in the bioreactor indicate 
that the cells expressing 2OG pathway preferably recycle 
NADH using native mixed-acid fermentation pathways 
instead of the heterologous pathway. The knock-out of 
mixed-acid fermentation pathways probably is neces-
sary to force NADH recycling using the heterologous 
pathway. These metabolic engineering strategies were 
coupled with other approaches to increment the 2OG 
availability and are ongoing.
Materials and methods
In silico analysis of heterologous pathways
Several alternative routes to produce n-butanol were gen-
erated using an hypergraph algorithm previously devel-
oped within our group [13] based on FindPath (FP) [48] 
using a proprietary database as the search space. The 
aim was to enumerate all possible combinations of reac-
tions leading from any reaction at the central carbon 
metabolism of Escherichia coli to n-butanol. The solu-
tions obtained were analyzed to select the most prom-
ising ones to implement in  vivo. The first step of this 
analytical process was to test if the pathways would allow 
butanol production when inserted in the iJO1366 E. coli 
GSMM [39]. This test was carried using FBA (flux bal-
ance analysis) with maximization of butanol flux as the 
objective function, for each pathway generated. Since 
stoichiometry is not considered by the enumeration algo-
rithm, the FBA simulations without butanol production 
(i.e., maximum butanol flux = 0) allowed to identify the 
stoichiometrically infeasible pathways. Pathways with-
out any butanol flux were discarded and diverse filters 
were successively applied to the remaining pathways. 
First, the pathways were sorted by size, i.e., the number 
of reactions needed to catalyze the initial precursor into 
butanol. Since clostridial pathway is constituted by six 
steps, the maximum threshold for pathway size was set 
to seven. Within the diverse groups sorted by size, the 
pathways were ranked accordingly to the conservation of 
number of carbon atoms (i.e., the difference between the 
number of carbons of the initial substrate and butanol). 
For the pathways with the greatest conservation of car-
bon atoms, a manual analysis was carried out.
To assure the novelty of the chosen pathways, the rel-
evant literature was searched for any previous reports 
of butanol production using the same set of reactions 
and the ones already reported were discarded. Then, 
the availability of curated gene sequences encoding the 
enzymes that catalyze the different reactions was verified 
by consulting databases such as UniProt [49], KEGG [14–
16], and MetaCyc [50]. For all the reactions constituting 
the most promising set of pathways, the change in Gibbs 
free energy (ΔrG′m) and Equilibrium constant (K′eq) were 
calculated using eQuilibrator 2.0 [17] to evaluate their 
reversibility. These values were estimated using Compo-
nent Contribution [51] considering reactants concentra-
tions of 1 mM, a pH of 7 and an ionic strength of 0.1 M.
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Genome‑scale model and software
The reactions constituting the most promising pathway 
obtained from the analysis described in the previous sec-
tion were again added to iJO1366 E. coli GSMM [39]. 
Additional file 3: Table S2 shows the stoichiometry of the 
reactions added to the model, as well as transport reac-
tion to allow the excretion of butanol. Reaction R01175 
was not added to the GSMM, since the model already 
includes this reaction (R_ACOAD1f). The reaction (S)-
3-hydroxybutanoyl-CoA hydrolyase (R_ECOAH1) was 
deleted from the GSMM to make sure that butanol pro-
duction originated from the heterologous pathway.
OptFlux3 [52] and FBA were used to perform all 
in silico analyses. n-Butanol production was stud-
ied under anaerobic (oxygen uptake flux was set to 
0  mmol  (gDW  h)−1) environmental conditions, with 
the glucose uptake rate set to 10  mmol  (gDW  h)−1 and 
ammonia, phosphate and sulfate uptake unconstrained 
and using butanol export reaction as the objective func-
tion. Flux variability analysis (FVA) allowed to infer the 
robustness of butanol production, i.e., to determine 
the flux limits of the active reactions under anaerobic 
conditions.
Strains and plasmids
The strains and plasmids used or constructed in this 
study as well as all the primers used are listed in Addi-
tional file 4: Tables S3, S4 and S5.
Cloning procedure
Basic molecular biology techniques were employed as 
previously described [53]. The genes used in this study 
were amplified by polymerase chain reaction (PCR) using 
Phusion High-Fidelity DNA Polymerase (Thermo Scien-
tific, Waltham, USA) in a LifeECO Thermal Cycler (Bioer 
Technology, Zhejiang, China). All primers were pur-
chased from Metabion (Munich, Germany). DNA frag-
ments were purified using DNA Clean and Concentrator 
DNA Kit (Zymo Research, Irvine, USA).
Plasmids were extracted using Plasmid Miniprep kit 
(Zymo Research). All digestions were performed using 
the appropriate  FastDigest® restriction endonucleases 
(Thermo Scientific). Ligations were performed with T4 
DNA Ligase (Thermo Scientific) and transformed by 
heat-shock in chemically competent E. coli NEB 5-alpha 
cells (New England BioLabs, Massachusetts, USA). The 
success of ligation was checked through Colony PCR 
using DreamTaq (Thermo Scientific) and further con-
firmed by sequencing (StabVida, Lisbon, Portugal). 
Protocols were performed in accordance with manufac-
turer’s instructions.
Shake flasks and sealed flasks experiments
Butanol production experiments were performed in Ter-
rific Broth (TB) medium [54] and high-density medium 
(HDM) adapted from [55].
TB medium contained, per liter, tryptone (12 g); yeast 
extract (24  g); glycerol (4  mL); monobasic potassium 
phosphate (2.31  g) and dibasic potassium phosphate 
(12.54 g). The pH of this medium was 7.2 ± 0.2 at 25 °C; 
adjustments were not necessary.
HDM formulation contained (per liter) dibasic sodium 
phosphate dihydrate (8.89  g); monobasic potassium 
phosphate (6.8 g); sodium chloride (0.58 g); magnesium 
sulphate (1.35  g); calcium chloride dihydrate (0.038  g); 
ammonium chloride (1 g); trace metals (250 µL); vitamins 
BME 100× (250 µL) and an amino acid mix (2 g).
The trace metals solution contained (per liter): 
 FeSO4·7H2O (30 mg);  ZnSO4·7H2O (45 mg);  CaCl2·2H2O 
(45  mg);  MnCl2·2H2O (100  mg);  CoCl2·6H2O (30  mg); 
 CuSO4·5H2O (30  mg);  Na2MoO4·2H2O (40  mg);  H3BO3 
(10  mg); KI (10  mg) and  Na2EDTA (1.5  g). The amino 
acid mix contained 1  g of adenine and 4  g of arginine, 
aspartate, glutamate, histidine, isoleucine, lysine, methio-
nine, phenylalanine, serine, threonine, tryptophan, tyros-
ine and valine. The vitamin BME 100× solution (Sigma 
Aldrich, St. Louis, MO, USA) contained (per liter): d-bio-
tin (0.1 g); choline chloride (0.1 g); folic acid (0.1 g); myo-
inositol (0.2 g); niacinamide (0.1 g); D-pantothenic acid. 
½Ca (0.1 g); riboflavin (0.01 g); thiamine·HCl (0.1 g) and 
NaCl (8.5 g). The pH of the medium was adjusted to 7.1 
at 25 °C using 2 M NaOH.
For strains expressing 2OG pathway, both media were 
supplemented, per liter, with 10 g glucose; 0.468 g gluta-
mate; 0.0753 g riboflavin and 0.525 g iron (III) citrate.
Luria–Bertani (LB) medium contained 10 g L−1 of pep-
tone; 5 g L−1 yeast extract and 5 g L−1 of NaCl. The solid 
version of this medium included 15 g L−1 agar.
All cultivations were performed with the addition of 
suitable antibiotics according to the employed plasmids. 
For OG and ACT strains, the antibiotics concentrations 
were 50 µg mL−1 ampicillin, 50 µg mL−1 spectinomycin, 
and 30 µg mL−1 kanamycin. For control strains, the con-
centrations employed were 50  µg  mL−1 ampicillin and 
30 µg mL−1 kanamycin.
A single colony was picked from LB plates and inocu-
lated in 10  mL of liquid LB medium. The pre-cultures 
were grown aerobically on a rotary shaker at 37  °C and 
200 rpm, overnight.
In HDM experiments, an appropriate volume of cells 
was harvested from the pre-culture by centrifugation 
(10 min at 3000×ɡ) and washed with HDM medium and 
then transferred to 500-mL shake flasks with 100 mL of 
medium, yielding an initial  OD600 of 0.1. In TB experi-
ments, an appropriate volume of pre-culture was 
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directly transferred to 500-mL shake flasks with 100 mL 
of medium, yielding an initial  OD600 of 0.1. These cul-
tures were also cultivated on a rotary shaker at 200 rpm 
at 37  °C. Butanol production genes were induced with 
0.5 mM IPTG at an  OD600 of 0.4–0.5.
To promote butanol production, after induction, the 
cells were switched to anaerobic conditions by transfer-
ring 60 mL of culture to 120-mL sealed serum flasks. The 
culture was supplemented with 600 µL of a 0.01 M stock 
solution of sodium bicarbonate to achieve a final concen-
tration of 10 mM, since it reduces long lag phases in E. coli 
anaerobic growth [56]. 60 µL of a solution of extra trace 
metals  [NiCl2 (1.7 mg L−1);  (NH4)6Mo7O24 (14.5 mg L−1); 
 4H2O  Na2SeO3 (2.4 mg L−1)] was supplied to the medium 
since selenium, nickel and molybdenum are part of the 
formate hydrogen lyase (FHL) complex, which is induced 
under anaerobic conditions [57]. After induction, the cul-
tures were incubated at 30 °C and 180 rpm, for 96 h.
Samples of broth were collected at time 0, induction 
time and 96 h for  OD600 measurements and high-perfor-
mance liquid chromatography (HPLC) and gas chroma-
tography–flame ionization detector (GC–FID) analysis 
of the supernatant. All experiments were performed in 
triplicate.
Bioreactor cultivations
Bioreactor fermentations were performed in HDM 
medium. Cells were pre-grown overnight in 500-mL shake 
flasks containing 100  mL of the same medium, at 37  °C 
and 200 rpm. Each fermenter was inoculated at an initial 
 OD600 of 0.15. The fermentations were performed in the 
Eppendorf DASGIP Parallel Bioreactor System (Switzer-
land) using 2-L culture vessels. The operating volume for 
the fermentations was 0.5 L, temperature was maintained 
at 37 °C, airflow at 1 VVM, pH was kept at 7.0 controlled 
by addition of 2 M NaOH, and dissolved oxygen was kept 
above 30% of saturation by feedback control of the stir-
ring speed from 200 rpm up to 400 rpm. Expression of the 
butanol genes was induced with 0.5  mM of IPTG when 
an  OD600 of 0.4–0.5 was reached. After IPTG induction, 
temperature was decreased to 30 °C and stirring speed to 
180  rpm. Anaerobic conditions were created by turning 
off the air flow and waiting for the leftover oxygen to be 
consumed. Samples were taken every 2 h for the first 12 h 
of the fermentation and, then, every 12  h. At each time 
point, the optical density was measured, and the superna-
tant was analyzed by HPLC and GC–FID.
Analytical methods
Butanol was quantified by GC and organic acids, ethanol 
and glucose by HPLC.
Samples were centrifuged at 6000×ɡ for 10 min to sep-
arate cells from the medium. Afterwards, the supernatant 
was filtered with a 0.22 µm pore filter membrane to glass 
vials and stored at − 20 °C until analyzed.
Quantitative analysis of organic acids and glucose was 
performed using a HPLC apparatus from Jasco (Japan) 
model LC-NetII/ADC equipped with UV-2075 Plus 
and RI-4030 Plus detectors, also from Jasco. The sam-
ples were analyzed using an Aminex HPX-87H column 
(300  mm × 7.7  mm) from Bio-Rad, which was kept at 
60 °C, and 5 mmol L−1  H2SO4 was used as mobile phase 
with a flow rate of 0.5  mL  min−1. Glucose and ethanol 
were detected with the refractive index (RI) detector and 
organic acids (succinate, lactate, formate and acetate) 
were detected at 210 nm using the UV detector. Calibra-
tion curves were obtained by injecting standards with 
known concentrations for each metabolite. Metabolite 
concentrations in samples were calculated by comparing 
the peak areas of the samples with the calibration curves.
Butanol concentration was quantified by a GP-9000 
system (Chrompack) with a Meta-WAX capillary col-
umn (30  m × 0.25  mm × 0.25  µm) equipped with a 
flame ionization detector (FID) where Helium was used 
as carrier gas with a flow rate of 1  mL  min−1. The fil-
tered supernatant (900 µL) was mixed with 100 µL of 
a 5 g L−1 solution of isobutanol, the internal standard, 
yielding a final concentration of 0.5 g L−1, and 1 µL of 
this mixture was injected. The temperatures of injec-
tor and detector were maintained at 250  °C. The col-
umn temperature was initially at 50 °C, heated to 177.5º 
C at a 5  °C  min−1 rate and then heated to 230  °C at 
10  °C min−1, which was held for 15 min. A calibration 
curve was obtained by injecting standards with several 
concentrations of butanol and a fixed concentration 
of internal standard (0.5  g  L−1 of isobutanol). Butanol 
concentration was calculated by comparing the ratio 
between its peak area and internal standard peak area 
with calibration curves.
All optical density measurements at 600 nm  (OD600) 
were performed using the spectrophotometer Ultro-
spec 10 from Biochrom (Cambridge, UK).
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